Aurinia Pharmaceuticals, Inc. (AUPH)
14.17
+0.20
(+1.43%)
USD |
NASDAQ |
Feb 27, 16:00
14.18
+0.01
(+0.07%)
Pre-Market: 20:00
Aurinia Pharmaceuticals Free Cash Flow : 135.69M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Xenon Pharmaceuticals, Inc. | -280.51M |
| Oncolytics Biotech, Inc. | -18.79M |
| Edesa Biotech, Inc. | -8.004M |
| Lexaria Bioscience Corp. | -8.775M |
| ProMIS Neurosciences, Inc. | -27.36M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 44.57M |
| Cash from Investing (Quarterly) | -36.89M |
| Cash from Financing (Quarterly) | -0.5114M |
| Free Cash Flow Per Share (Quarterly) | 0.3221 |
| Free Cash Flow to Equity (Quarterly) | 47.90M |
| Free Cash Flow to Firm (Quarterly) | 50.69M |
| Free Cash Flow Yield | 6.90% |